10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.43% | -13.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.43% | -13.83% | |||
| Cost of Revenue | 8.60% | 2.68% | |||
| Gross Profit | 12.80% | -20.06% | |||
| SG&A Expenses | -2.19% | 2.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.62% | 1.74% | |||
| Operating Income | 50.41% | -592.77% | |||
| Income Before Tax | 46.13% | -176.24% | |||
| Income Tax Expenses | 244.47% | -129.81% | |||
| Earnings from Continuing Operations | 40.84% | -179.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.84% | -179.54% | |||
| EBIT | 50.41% | -592.77% | |||
| EBITDA | 73.75% | -751.29% | |||
| EPS Basic | 41.57% | -178.43% | |||
| Normalized Basic EPS | 53.61% | -1,223.93% | |||
| EPS Diluted | 41.57% | -178.43% | |||
| Normalized Diluted EPS | 53.61% | -1,233.62% | |||
| Average Basic Shares Outstanding | 1.26% | 1.41% | |||
| Average Diluted Shares Outstanding | 1.26% | 0.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||